Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002312802 | SCV000847303 | benign | Inborn genetic diseases | 2016-06-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001510201 | SCV001717183 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001510201 | SCV001942167 | benign | not provided | 2018-12-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002507254 | SCV002802626 | likely benign | Smith-Magenis syndrome | 2022-05-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001510201 | SCV005248522 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003980338 | SCV004799476 | benign | RAI1-related disorder | 2019-05-08 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |